Got some time for a brew and a chat? Mentell, an incredible charity offering safe, confidential spaces for men to talk, is launching a brand-new Circle in Buxton this month. These free weekly meetings give men the chance to open up, listen, and connect - no pressure, no judgment. To celebrate the launch, Mentell is hosting a relaxed Coffee & Chat event:  Tuesday, 15th July  Grapevine Wellbeing Centre, Buxton  Free drinks & friendly faces Come along to m...

We're delighted to announce that we are sponsoring a charity stand at the BAUN Annual Conference in Edinburgh this November. Urological nurses play a vital and growing role in the prostate cancer diagnosis pathway - taking on advanced procedures such as biopsies, supporting patients throughout their treatment, and driving improvements in care. We’re proud to support them at this important event. The British Association of Urological Nurses (BAUN) is the UK’s leading org...

Veteran broadcaster Dermot Murnaghan, best known for presenting the BBC’s News at Ten, Sky News, and the quiz show Eggheads, has revealed he is living with stage 4 prostate cancer. In a deeply personal message shared on social media, the 67-year-old urged men to get tested, stressing that early detection is vital and that prostate cancer can progress without any noticeable symptoms. “I’m responding positively to their excellent treatment, and feeling well. Needle...

June is Men’s Health Month, bringing global focus to the importance of preventive care, healthy habits, and early detection - especially for prostate cancer, which remains a leading cancer in men. Early diagnosis dramatically boosts survival, with a 5‑year survival rate of about 99% when caught early.  What GFCT Offers in PSA Testing Since 2004, The Graham Fulford Charitable Trust (GFCT) has been bringing early prostate cancer detection directly into communit...

Graham Fulford, founder of GFCT and GFCT Focal Therapy, was diagnosed with prostate cancer early this year. An update from Graham: My Personal Journey Continues Dear all, I mentioned in my last update that I was having a Prostatype test as part of my ongoing active surveillance and I can report that the results are now in. They indicate that I'm at low risk of mortality from prostate cancer in the next 10 years - so it's off to the pub to celebrate later! As...

A new artificial intelligence (AI) test could revolutionise prostate cancer treatment by identifying which men are most likely to benefit from abiraterone—a life-extending drug that halves the risk of death in certain patients. Abiraterone has already helped hundreds of thousands of men with advanced prostate cancer. However, access remains limited in places like England for men whose cancer has not yet spread. That could soon change, thanks to an exciting development from a team of r...

Former President Joe Biden, 82, has been diagnosed with advanced prostate cancer that has spread to his bones. Detected after he reported urinary symptoms, the cancer is aggressive (Gleason score 9), but doctors say it is hormone-sensitive and manageable. Biden and his family are reviewing treatment options. Support has poured in from across the political spectrum, including Donald Trump, Kamala Harris, and Barack Obama. Read the full BBC article - https://www.bbc.co.uk/news/artic...

Early detection saves lives – and it starts with a simple blood test. Prostate Cymru is leading an ambitious campaign across Wales to provide free or low-cost PSA tests to thousands of men, helping to catch prostate cancer early – when it's most treatable. Men often avoid testing due to outdated fears or lack of awareness. But the PSA test is quick, painless and finger-free. It's already flagged early signs of cancer in dozens of men –...

We’re proud to have been involved in the recent Prostate Cancer Conference at The Christie, jointly organised by Prostate Cancer Support (PCS) and The Graham Fulford Charitable Trust (GFCT). Our friends at South Warwickshire Prostate Cancer Support Group (SWaPS) have written a fantastic summary of the day, and we’d love to share their blog:  On May 17th, Doug Badger our Chair attended a conference, jointly organised by Prostate Cancer Support (PCS) and the Graham Fulford Ch...

New research by University of Manchester using GFCT test results data highlights the power of community-based PSA testing in prostate cancer risk detection. Article: Charity-Provided Community-Based PSA Testing for Assessment of Prostate Cancer Risk in the UK: Clinical Implications and Future Opportunities By Artitaya Lophatananon, Graham Fulford, Jon Young, Susan Hart, Matthew Brine and Kenneth R. Muir. Prostate cancer is the most common cancer in men across the UK...